Latest pharmaceutical industry News

KnowBe4’s Annual Phishing Benchmarking Report Shows Focusing on the Human Element Still the Best Safeguard Against Cyber Threats
Why, for some, psychotherapy might be a better treatment for depression than drugs
Asymchem Welcomes Franck Mevellec as Senior Director, Business Development
‘Cloaked’ proteins deliver cancer-killing therapeutics into cells
New health research hub to improve patient care and build health workforce in Victoria’s northern corridor
Drug companies pay doctors over A$11 million a year for travel and education. Here’s which specialties received the most
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
NACCHO 2024 Aboriginal and Torres Strait Islander Pharmacist Scholarship recipients announced
Industry applauds $18.8m funding for National One Stop Shop for clinical trials
We looked at genetic clues to depression in more than 14,000 people. What we found may surprise you
Setting new standards for healthcare: DB Schenker secures Good Distribution Practice (GDP) certification for more than 150 stations
IIdentification of Tropane Alkaloid Chemotypes and Genotypes in Hyoscyamus niger L
Ministerial Visit Focuses On Alzheimer’s Disease
LBT Innovations announces that its APAS PharmaQC product is commercially ready
Vaccine-skeptical mothers say bad health care experiences made them distrust the medical system
Acquisition Of Gracell Completed
Acquisition of Icosavax Completed
MinterEllison advises Arrotex on key health and beauty acquisitions
AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases
AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase II data
Revealing the Landscape of Software as a Medical Device Industry
More than skin-deep
Antimicrobial Resistance: Silent Pandemic
New director for WEHI
With ACT and NZ First promising to overhaul Pharmac, what’s in store for publicly funded medicines?
New electronic WHO Prequalification System (ePQS) Portal set to launch by January 2024
US academic gains fresh perspective teaching in NZ
Eight essential leadership capabilities for 21st century
Engineering of plant cell wall modifying enzymes opens new horizons
Botanix Pharmaceuticals elevates chief operating officer to CEO position
New DNA drug to fight blood clots
Pills from 3D printer
Unemployment and underemployment significant drivers of suicide: analysis
Cynata Therapeutics announces CEO succession and board changes
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development
Pharmacy Connect conference early-bird discount – one month to go
Researchers develop a new approach to scale-up manufacturing of life-saving oligonucleotide therapeutics
Do sleep apps help with insomnia?
A Novel High-Throughput Method for Screening Protein-Secreting Microbial Strains
New CDU studies finds two native Australian plants have healing properties
New CDU study finds two native Australian plants have healing properties
Surviving childhood cancer – Luca’s story
NACCHO 2023 Aboriginal and Torres Strait Islander Pharmacist Scholarship recipients announced
Curing childhood cancer: all roads lead to Melbourne
Neuren Pharmaceuticals appoints experienced industry executive to board
New Deputy Mayor for City of Ryde
New collaboration targets better bone health and ageing
Optimized Amide Bond Reaction Using Heterocyclic Compounds and Carboxylic Acid